Utama › Fibrosis Paru Idiopatik › Tennessee
Kajian klinikal Fibrosis Paru Idiopatik di Tennessee
6 kajian untuk Fibrosis Paru Idiopatik sedang mencari peserta di lokasi di Tennessee.
Bandar di Tennessee
Teks kajian rasmi (Bahasa Inggeris)
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06951217RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Alliance for Multispecialty Research Clinical, Knoxville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Clinical Trials Center of Middle Tennesee LLC, Franklin
Mengambil pesertaFasa 3
Umur 40 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284602Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Vanderbilt University, Nashville
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Nashville, TN, Nashville
Mengambil pesertaFasa 2
Umur 40 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06967805Mechanisms of Familial Pulmonary Fibrosis
- Vanderbilt University Medical Center, Nashville
Mengambil pesertaKajian pemerhatian
Umur 40 hingga 75 · Semua jantina · Dikemas kini 31 Dis 2025 · NCT03437486Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.